Design, Synthesis and Bioactivity of Polypeptide ACE Inhibitors

ZHOU Jiaqi; MA Chunyan; LI Xiaohui

doi:10.13386/j.issn1002-0306.2022030117

Volume 43 Issue 23

Nov. 2022

Turn off MathJax

Article Contents

Abstract

References

Science and Technology of Food Industry > 2022 > 43(23): 26-34. > DOI: 10.13386/j.issn1002-0306.2022030117

ZHOU Jiaqi, MA Chunyan, LI Xiaohui. Design, Synthesis and Bioactivity of Polypeptide ACE Inhibitors[J]. Science and Technology of Food Industry, 2022, 43(23): 26−34. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2022030117.

Citation:

PDF (6692 KB)

Design, Synthesis and Bioactivity of Polypeptide ACE Inhibitors

1.
College of Bioengineering, Dalian University of Technology, Dalian 116024, China
2.
College of Chemical Engineering, Dalian University of Technology, Dalian 116024, China

More Information

Received Date: March 09, 2022
Available Online: October 08, 2022

Graphical Abstract

Abstract

Abstract

In this study, using angiotensin converting enzyme (ACE) inhibitory peptides PHP1 and PHP2 as the parent peptides, the hydrophobicity and electrical properties of target polypeptides were altered by substituting amino acid residues. In addition, the potential bioactivity of these polypeptides was assessed using bioinformatics tools. Following this analysis, 19 polypeptide analogues were designed and synthesized using solid-phase synthesis, and their bioactivities were detected in vitro. The results revealed that the polypeptide analogues showed relatively high ACE inhibitory activities, PHP1A-6 (IC₅₀=3.87 μmol/L), PHP2A-3 (IC₅₀=3.33 μmol/L), PHP2A-4 (IC₅₀=2.86 μmol/L), and PHP2A-7 (IC₅₀=4.58 μmol/L) exhibited the highest ACE inhibitory activity levels, significantly higher than the parent peptides (P<0.05). PHP1A-3, PHP1A-4, PHP1A-7, PHP2A-1 and PHP2A-10 displayed equal levels of inhibitory activity in comparison to the parent peptides (IC₅₀<10 μmol/L). Compared with the parent peptides, the α-glucosidase inhibitory activity levels demonstrated by most of the polypeptide analogues were significantly enhanced, PHP1A-3 (IC₅₀=3.09 μmol/L), PHP1A-7 (IC₅₀=9.51 μmol/L), PHP2A-6 (IC₅₀=5.58 μmol/L), PHP2A-11 (IC₅₀=2.35 μmol/L), and PHP2A-12 (IC₅₀=3.98 μmol/L) exhibited the highest activities. Additionally, PHP1A-3 and PHP1A-7 displayed relatively strong inhibitory activity against both ACE and α-glucosidase. At concentrations of 1 mg/mL, the polypeptides containing Cys displayed an ABTS⁺· scavenging rate of higher than 85%, demonstrating a potential antioxidant activity. The structure-activity relationship between the ACE inhibitory peptides and ACE were explored using molecular docking. The results reflected that inhibitory peptides produced multiple stable hydrogen bonds, hydrophobic interactions, π-π stacking interactions, and salt bridges with ACE amino acid residues, thereby improving the inhibitory effects exerted on ACE.
- solid-phase peptide synthesis,
- novel ACE inhibitory peptide analogue,
- biological activity,
- molecular docking

FullText(HTML)

References (44)

References

[1]	WEI D, FAN W L, XU Y. Identification of water-soluble peptides in distilled spent grain and its angiotensin converting enzyme (ACE) inhibitory activity based on UPLC-Q-TOF-MS and proteomics analysis[J]. Food Chemistry,2021,353(15):129521.
[2]	MELO J A F, DALPIAZ P L M, ESCOUTO L D S, et al. Involvement of sex hormones, oxidative stress, ACE and ACE2 activity in the impairment of renal function and remodelling in SHR[J]. Life Sciences,2020,257(15):118138.
[3]	XU Z Q, WU C P, SUN W D, et al. Identification of post-digestion angiotensin-I converting enzyme (ACE) inhibitory peptides from soybean protein isolate: Their production conditions and in silico molecular docking with ACE[J]. Food Chemistry,2021,345(30):128855.
[4]	FAN Y, YU Z P, ZHAO W Z, et al. Identification and molecular mechanism of angiotensin-converting enzyme inhibitory peptides from Larimichthys crocea Titin[J]. Food Science and Human Wellness,2020,9(3):257−263. doi: 10.1016/j.fshw.2020.04.001
[5]	LI M Y, FAN W L, XU Y. Identification of angiotensin converting enzyme (ACE) inhibitory and antioxidant peptides derived from Pixian broad bean paste[J]. LWT,2021,151(3):112221.
[6]	GIACOMETTI C F, PARRA B D, DOMINGUES G B, et al. High protein yogurt with addition of Lactobacillus helveticus: Peptide profile and angiotensin-converting enzyme ACE-inhibitory activity[J]. Food Chemistry,2020,333(6):127482.
[7]	GONZALEZ A J A, CABRERA D Z, MATALLANA A M, et al. In-silico design of new enalapril analogs (ACE inhibitors) using QSAR and molecular docking models[J]. Informatics in Medicine Unlocked,2020,19(13):100336.
[8]	ISHAK N H, SHAIK M I, YELLAPU N K, et al. Purification, characterization and molecular docking study of angiotensin-I converting enzyme (ACE) inhibitory peptide from shortfin scad (Decapterus macrosoma) protein hydrolysate[J]. Journal of Food Science and Technology,2021,58(12):4567−4577. doi: 10.1007/s13197-020-04944-y
[9]	GUO Y T, WANG K, WU B G, et al. Production of ACE inhibitory peptides from corn germ meal by an enzymatic membrane reactor with a novel gradient diafiltration feeding working-mode and in vivo evaluation of antihypertensive effect[J]. Journal of Functional Foods,2020,64(9):103584.
[10]	CHAMATA Y, WATSON K A, JAUREGI P. Whey-derived peptides interactions with ACE by molecular docking as a potential predictive tool of natural ACE inhibitors[J]. International Journal of Molecular Sciences,2020,21(3):864. doi: 10.3390/ijms21030864
[11]	ZOHRAB F, ASKARIAN S, JALILI A, et al. Biological properties, current applications and potential therapeautic applications of brevinin peptide superfamily[J]. International Journal of Peptide Research and Therapeutics,2019,25(1):39−48. doi: 10.1007/s10989-018-9723-8
[12]	SU L Y, XIN H Y, LIU Y L, et al. Anticancer bioactive peptide (ACBP) inhibits gastric cancer cells by upregulating growth arrest and DNA damage-inducible gene 45A (GADD45A)[J]. Tumor Biology,2014,35(10):10051−10056. doi: 10.1007/s13277-014-2272-7
[13]	MIRZAEI M, MIRDAMADI S, SAFAVI M, et al. In vitro and in silico studies of novel synthetic ACE-inhibitory peptides derived from Saccharomyces cerevisiae protein hydrolysate[J]. Bioorganic Chemistry,2019,87(1):647−654.
[14]	ACHARYA K R, STURROCK E D, RIORDAN J F, et al. Ace revisited: A new target for structure-based drug design[J]. Nature Reviews Drug Discovery,2003,2(11):891−902. doi: 10.1038/nrd1227
[15]	WU J, ALUKO R E, NAKAI S. Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure-activity relationship study of di- and tripeptides[J]. Journal of Agricultural and Food Chemistry,2006,54(3):732−738. doi: 10.1021/jf051263l
[16]	KO J Y, KANG N, LEE J H, et al. Angiotensin I-converting enzyme inhibitory peptides from an enzymatic hydrolysate of flounder fish (Paralichthys olivaceus) muscle as a potent anti-hypertensive agent[J]. Journal of Agricultural and Food Chemistry,2016,51(4):535−541.
[17]	GUERRERO L, CASTILLO J, QUIÑONES M, et al. Inhibition of angiotensin-converting enzyme activity by flavonoids: Structure-activity relationship studies[J]. PLoS One,2012,7(11):e49493. doi: 10.1371/journal.pone.0049493
[18]	ZHANG P, CHANG C, LIU H J, et al. Identification of novel angiotensin I-converting enzyme (ACE) inhibitory peptides from wheat gluten hydrolysate by the protease of Pseudomonas aeruginosa[J]. Journal of Functional Foods,2020,65(5):103751.
[19]	GARCÍA M P, MARTÍN M M, ANGELES B M, et al. Identification, functional gastrointestinal stability and molecular docking studies of lentil peptides with dual antioxidant and angiotensin I converting enzyme inhibitory activities[J]. Food Chemistry,2017,221(26):464−472.
[20]	MIRZAEI M, MIRDAMADI S, SAFAVI M. Structural analysis of ACE-inhibitory peptide (VL-9) derived from kluyveromyces marxianus protein hydrolysate[J]. Journal of Molecular Structure,2020,1213(5):128199.
[21]	ASHOK A, BRIJESHA N, APARNA H S. Discovery, synthesis, and in vitro evaluation of a novel bioactive peptide for ACE and DPP-IV inhibitory activity[J]. European Journal of Medicinal Chemistry,2019,180(15):99−110.
[22]	DENG X, MAI R Y, ZHANG C Y, et al. Synthesis and pharmacological evaluation of a novel synthetic peptide CWHTH based on the styela clava-derived natural peptide LWHTH with improved antioxidant, hepatoprotective and angiotensin converting enzyme inhibitory activities[J]. International Journal of Pharmaceutics,2021,605(10):120852.
[23]	AMSO Z, KOWALCZYK R, WATSON M, et al. Structure activity relationship study on the peptide hormone preptin, a novel bone-anabolic agent for the treatment of osteoporosis[J]. Organic & Biomolecular Chemistry,2016,14(39):9225−9238.
[24]	YU Y K, HU J E, MIYAGUCHI Y, et al. Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from porcine hemoglobin[J]. Peptides,2006,27(11):2950−2956. doi: 10.1016/j.peptides.2006.05.025
[25]	HUI L X, LI Y H, EN H J, et al. Synthesis and biological activities of hemoglobin fragments[J]. Chemical Research in Chinese Universities,2008,29(3):542−545.
[26]	GASTEIGER E, HOOGLAND C, GATTIKER A, et al. Protein identification and analysis tools on the ExPASy server[M]. Paterson: Humana Press, 2005: 571-607.
[27]	KUMAR R, CHAUDHARY K, SINGH C J, et al. An in silico platform for predicting, screening and designing of antihypertensive peptides[J]. Scientific Reports,2015,5(1):12512. doi: 10.1038/srep12512
[28]	MOONEY C, HASLAM N J, POLLASTRI G, et al. Towards the improved discovery and design of functional peptides: Common features of diverse classes permit generalized prediction of bioactivity[J]. PloS One,2012,7(10):e45012. doi: 10.1371/journal.pone.0045012
[29]	ZHANG Y, HE S D, RUI X, et al. Interactions of C. frondosa-derived inhibitory peptides against angiotensin I-converting enzyme (ACE), α-amylase and lipase[J]. Food Chemistry,2022,367(1):130695.
[30]	KAISER E, COLESCOTT R L, BOSSINGER C D, et al. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides[J]. Analytical Biochemistry,1970,34(2):595−598. doi: 10.1016/0003-2697(70)90146-6
[31]	骆琳, 丁青芝, 马海乐. 96孔板法用于高通量血管紧张素转化酶抑制剂体外检测[J]. 分析化学,2012,40(1):129−134. [LUO L, DING Q Z, MA H L. Establishment of in vitro high-throughputactivity detection method for angiotensin converting enzyme inhibitors based on 96 well plates[J]. Chinese Journal of Analytical Chemistry,2012,40(1):129−134.
[32]	XU H W, DAI G F, LIU G Z, et al. Synthesis of andrographolide derivatives: A new family of α-glucosidase inhibitors[J]. Bioorganic & Medicinal Chemistry,2007,15(12):4247−4255.
[33]	LIU C, LIU J B, WANG M Q, et al. Construction and application of membrane-bound angiotensin-I converting enzyme system: A new approach for the evaluation of angiotensin-I converting enzyme inhibitory peptides[J]. Journal of Agricultural and Food Chemistry,2020,68(20):5723−5731. doi: 10.1021/acs.jafc.9b08082
[34]	HAO L, GAO X C, ZHOU T Y, et al. Angiotensin I-converting enzyme (ACE) inhibitory and antioxidant activity of umami peptides after in vitro gastrointestinal digestion[J]. Journal of Agricultural and Food Chemistry,2020,68(31):8232−8241. doi: 10.1021/acs.jafc.0c02797
[35]	林凯. 基于结构信息学定向水解曲拉酪蛋白及新型降压肽的研究[D]. 哈尔滨: 哈尔滨工业大学, 2020 LIN K. Screening of novel antihypertensive peptides by directed hydrolysis in Qula casein based on the structural informatics[D]. Harbin: Harbin Institute of Technology, 2020
[36]	IBRAHIM H R, AHMED A S, MIYATA T. Novel angiotensin-converting enzyme inhibitory peptides from caseins and whey proteins of goat milk[J]. Journal of Advanced Research,2017,8(1):63−71. doi: 10.1016/j.jare.2016.12.002
[37]	GUANG C, PHILLIPS R D. Plant food-derived angiotensin I converting enzyme inhibitory peptides[J]. Journal of Agricultural and Food Chemistry,2009,57(12):5113−5120. doi: 10.1021/jf900494d
[38]	MAESTRI E, PAVLICEVIC M, MONTORSI M, et al. Meta-analysis for correlating structure of bioactive peptides in foods of animal origin with regard to effect and stability[J]. Comprehensive Reviews in Food Science and Food Safety,2019,18(1):3−30. doi: 10.1111/1541-4337.12402
[39]	IBRAHIM M A, BESTER M J, NEITZ A W H, et al. Structural properties of bioactive peptides with α-glucosidase inhibitory activity[J]. Chemical Biology & Drug Design,2018,91(2):370−379.
[40]	MUDGIL P, KAMAL H, PRIYA K B, et al. Simulated gastrointestinal digestion of camel and bovine casein hydrolysates: Identification and characterization of novel anti-diabetic bioactive peptides[J]. Food Chemistry,2021,353(15):129374.
[41]	ZHAO Q, WEI G Q, LI K L, et al. Identification and molecular docking of novel α-glucosidase inhibitory peptides from hydrolysates of Binglangjiang buffalo casein[J]. LWT,2022,156(15):113062.
[42]	ARISE R O, IDI J J, MIC B I M, et al. In vitro angiotesin-1-converting enzyme, α-amylase and α-glucosidase inhibitory and antioxidant activities of Luffa cylindrical (L. ) M. Roem seed protein hydrolysate[J]. Heliyon,2019,5(5):e01634. doi: 10.1016/j.heliyon.2019.e01634
[43]	ZHENG L, ZHAO Y J, DONG H Z, et al. Structure–activity relationship of antioxidant dipeptides: Dominant role of Tyr, Trp, Cys and Met residues[J]. Journal of Functional Foods,2016,21(13):485−496.
[44]	MIRZAEI M, MIRDAMADI S, SAFAVI M, et al. The stability of antioxidant and ACE-inhibitory peptides as influenced by peptide sequences[J]. LWT,2020,130(26):109710.

Supplements (0)

Cited By

Cited by

Periodical cited type(7)

1.	夏小雨，温财兴，曹文红，秦小明，李钰金，林海生，陈忠琴，郑惠娜，朱国萍，高加龙. 基于表面等离子体共振技术筛选马氏珠母贝肉酶解产物中血管紧张素转换酶抑制肽. 食品科学. 2025(07): 143-150 .
2.	吴靖娜，洪乔茜，廖榕榕，蔡水淋，陈晓婷，苏海燕，苏筱，许莉，潘南，卓诗晴. 红毛藻血管紧张素转化酶抑制肽的筛选及其稳定性评价. 食品科学. 2024(02): 188-194 .
3.	郭星晨，李玉豪，马金璞，张钰璇，李华鑫，杨具田，樊佩如，高丹丹. 基于氨基酸描述符对血管紧张素转化酶抑制五肽定量构效关系分析. 食品科学. 2024(13): 38-48 .
4.	钟玉旺，于梦怡，张丹，常莹，幸福兵，黄艾祥，王雪峰. 辣木籽凝乳酶在水牛乳干酪制备中应用及产血管紧张素转化酶抑制肽分析. 食品科学. 2024(18): 87-98 .
5.	王海东，张涵，周泓妍，史佳琳，石雨欣，衣春光，张红印，严铭铭. 响应面法优化五味子蛋白肽的制备工艺及其体外抗氧化活性. 食品工业科技. 2024(19): 166-176 . 本站查看
6.	杨志雨，王广慧，孟涓涓，郑晓宇，徐丽晶，韩昊霖. 响应面优化超声波辅助酶解法制备金针菇ACE抑制肽. 湖北农业科学. 2024(11): 153-159+167 .
7.	杨明哲，赵子莹，汤华成，李良玉，彭思念，李志江. 植物源咸味肽制备与应用研究进展. 食品工业科技. 2023(20): 467-474 . 本站查看